These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 25426976)

  • 1. IgG antibodies to cyclic citrullinated peptides exhibit profiles specific in terms of IgG subclasses, Fc-glycans and a fab-Peptide sequence.
    Lundström SL; Fernandes-Cerqueira C; Ytterberg AJ; Ossipova E; Hensvold AH; Jakobsson PJ; Malmström V; Catrina AI; Klareskog L; Lundberg K; Zubarev RA
    PLoS One; 2014; 9(11):e113924. PubMed ID: 25426976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid.
    Scherer HU; van der Woude D; Ioan-Facsinay A; el Bannoudi H; Trouw LA; Wang J; Häupl T; Burmester GR; Deelder AM; Huizinga TW; Wuhrer M; Toes RE
    Arthritis Rheum; 2010 Jun; 62(6):1620-9. PubMed ID: 20178128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis.
    Rombouts Y; Ewing E; van de Stadt LA; Selman MH; Trouw LA; Deelder AM; Huizinga TW; Wuhrer M; van Schaardenburg D; Toes RE; Scherer HU
    Ann Rheum Dis; 2015 Jan; 74(1):234-41. PubMed ID: 24106048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Analysis of Variable Domain Glycosylation of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Reveals the Presence of Highly Sialylated Glycans.
    Hafkenscheid L; Bondt A; Scherer HU; Huizinga TW; Wuhrer M; Toes RE; Rombouts Y
    Mol Cell Proteomics; 2017 Feb; 16(2):278-287. PubMed ID: 27956708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin (Ig)G1 and IgG4 anti-cyclic citrullinated peptide (CCP) associate with shared epitope, whereas IgG2 anti-CCP associates with smoking in patients with recent-onset rheumatoid arthritis (the Swedish TIRA project).
    Martinsson K; Johansson A; Kastbom A; Skogh T
    Clin Exp Immunol; 2017 Apr; 188(1):53-62. PubMed ID: 27859022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The concentration of anticitrullinated protein antibodies in serum and synovial fluid in relation to total immunoglobulin concentrations.
    Willemze A; Shi J; Mulder M; Stoeken-Rijsbergen G; Drijfhout JW; Huizinga TW; Trouw LA; Toes RE
    Ann Rheum Dis; 2013 Jun; 72(6):1059-63. PubMed ID: 23486413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis.
    Bos WH; Bartelds GM; Vis M; van der Horst AR; Wolbink GJ; van de Stadt RJ; van Schaardenburg D; Dijkmans BA; Lems WF; Nurmohamed MT; Aarden L; Hamann D
    Ann Rheum Dis; 2009 Apr; 68(4):558-63. PubMed ID: 18445623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fc gamma receptor binding profile of anti-citrullinated protein antibodies in immune complexes suggests a role for FcγRI in the pathogenesis of synovial inflammation.
    Kempers AC; Nejadnik MR; Rombouts Y; Ioan-Facsinay A; van Oosterhout M; Jiskoot W; Huizinga TWJ; Toes REM; Scherer HU
    Clin Exp Rheumatol; 2018; 36(2):284-293. PubMed ID: 29352854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis.
    Rombouts Y; Willemze A; van Beers JJ; Shi J; Kerkman PF; van Toorn L; Janssen GM; Zaldumbide A; Hoeben RC; Pruijn GJ; Deelder AM; Wolbink G; Rispens T; van Veelen PA; Huizinga TW; Wuhrer M; Trouw LA; Scherer HU; Toes RE
    Ann Rheum Dis; 2016 Mar; 75(3):578-85. PubMed ID: 25587188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD95-Mediated control of anti-citrullinated protein/peptides antibodies (ACPA)-producing plasma cells occurring in rheumatoid arthritis inflamed joints.
    Rodríguez-Bayona B; Pérez-Venegas JJ; Rodríguez C; Brieva JA
    Rheumatology (Oxford); 2007 Apr; 46(4):612-6. PubMed ID: 17132692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG Subclass Specificity Discriminates Restricted IgM Rheumatoid Factor Responses From More Mature Anti-Citrullinated Protein Antibody-Associated or Isotype-Switched IgA Responses.
    Falkenburg WJ; van Schaardenburg D; Ooijevaar-de Heer P; Wolbink G; Rispens T
    Arthritis Rheumatol; 2015 Dec; 67(12):3124-34. PubMed ID: 26246004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint.
    Ossipova E; Cerqueira CF; Reed E; Kharlamova N; Israelsson L; Holmdahl R; Nandakumar KS; Engström M; Harre U; Schett G; Catrina AI; Malmström V; Sommarin Y; Klareskog L; Jakobsson PJ; Lundberg K
    Arthritis Res Ther; 2014 Aug; 16(4):R167. PubMed ID: 25112157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies.
    Jaskowski TD; Hill HR; Russo KL; Lakos G; Szekanecz Z; Teodorescu M
    J Rheumatol; 2010 Aug; 37(8):1582-8. PubMed ID: 20516016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA.
    Engelmann R; Brandt J; Eggert M; Karberg K; Krause A; Neeck G; Mueller-Hilke B
    Rheumatology (Oxford); 2008 Oct; 47(10):1489-92. PubMed ID: 18703528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in anti-citrullinated protein antibody isotype levels in relation to disease activity and response to treatment in early rheumatoid arthritis.
    Kastbom A; Roos Ljungberg K; Ziegelasch M; Wetterö J; Skogh T; Martinsson K
    Clin Exp Immunol; 2018 Dec; 194(3):391-399. PubMed ID: 30136282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients.
    van Delft MAM; Verheul MK; Burgers LE; Derksen VFAM; van der Helm-van Mil AHM; van der Woude D; Huizinga TWJ; Toes REM; Trouw LA
    Arthritis Res Ther; 2017 Aug; 19(1):190. PubMed ID: 28810902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Linked Glycans in the Variable Domain of IgG Anti-Citrullinated Protein Antibodies Predict the Development of Rheumatoid Arthritis.
    Hafkenscheid L; de Moel E; Smolik I; Tanner S; Meng X; Jansen BC; Bondt A; Wuhrer M; Huizinga TWJ; Toes REM; El-Gabalawy H; Scherer HU
    Arthritis Rheumatol; 2019 Oct; 71(10):1626-1633. PubMed ID: 31067000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis.
    Dewint P; Hoffman IE; Rogge S; Joos R; Union A; Dehoorne J; Delanghe J; Veys EM; De Keyser F; Elewaut D
    Rheumatology (Oxford); 2006 Feb; 45(2):204-8. PubMed ID: 16188943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synovial fluid mononuclear cells provide an environment for long-term survival of antibody-secreting cells and promote the spontaneous production of anti-citrullinated protein antibodies.
    Kerkman PF; Kempers AC; van der Voort EI; van Oosterhout M; Huizinga TW; Toes RE; Scherer HU
    Ann Rheum Dis; 2016 Dec; 75(12):2201-2207. PubMed ID: 27069015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives.
    Hitchon CA; Chandad F; Ferucci ED; Willemze A; Ioan-Facsinay A; van der Woude D; Markland J; Robinson D; Elias B; Newkirk M; Toes RM; Huizinga TW; El-Gabalawy HS
    J Rheumatol; 2010 Jun; 37(6):1105-12. PubMed ID: 20436074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.